InvestorsHub Logo
Followers 9
Posts 442
Boards Moderated 0
Alias Born 01/20/2014

Re: Couch post# 94332

Friday, 03/07/2014 12:25:07 PM

Friday, March 07, 2014 12:25:07 PM

Post# of 404597
Thanks Couch. ELI-200 / ELI-201 / ELI-216 / ELI-154

Here is updated list, hope I have them right...Lasers can you also verify :)

ELI-200: Undisclosed Abuse Deterrent opioid (most likely is Morphine/Naltrexone better EMBEDA). BE study done and good result. Even though this was second BE study but will be first NDA to be filed with FDA in 2014.

ELI-201: Oxycodone/Naltrexone twice-daily with ART/ADT. BE Study done and good result. Will be filed NDA with FDA in 2014. Three different twice daily formulations developed by Elite were tested in the study. This generic of OxyContin.

ELI-216: Oxycodone/Naltrexone once-daily with ART/ADT

ELI-154: Oxycodone twice-daily ER with no ART/ADT , this might be marketed in Europe, right?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News